Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Gynecologic Oncology|September 26, 2022
Clinical outcomes in patients with COVID-19 and gynecologic cancer: A society of gynecologic oncology COVID-19 and gynecologic cancer registry studyGretchen E Glaser, Olivia D Lara, Bhavana Pothuri, et al.
Gynecologic Oncology|August 4, 2017
Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?Amanda N Fader, Jennifer Bergstrom, Amelia Jernigan, et al.
Gynecologic Oncology|October 17, 2016
Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysisAmanda N Fader, James Java, Meaghan Tenney, et al.
Obstetrics and Gynecology|September 9, 2017
Outcomes Associated With a Five-Point Surgical Site Infection Prevention Bundle in Women Undergoing Surgery for Ovarian CancerMelissa H Lippitt, Melissa Gerardi Fairbairn, Rayna Matsuno, et al.
Brachytherapy|March 18, 2018
Interventional Radiation Oncology (IRO): Transition of a magnetic resonance simulator to a brachytherapy suiteRoberta Anderson, Elwood Armour, Courtney Beeckler, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 17, 2023
Low-grade serous ovarian cancer: expert consensus report on the state of the scienceRachel N Grisham, Brian M Slomovitz, Nicole Andrews, et al.
Gynecologic Oncology|June 14, 2020
When to Operate, Hesitate and Reintegrate: Society of Gynecologic Oncology Surgical Considerations during the COVID-19 PandemicAmanda N Fader, Warner K Huh, Joshua Kesterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 28, 2018
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neuAmanda N Fader, Dana M Roque, Eric Siegel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2020
Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival AnalysisAmanda N Fader, Dana M Roque, Eric Siegel, et al.
Gynecologic Oncology|August 21, 2025
A randomized pilot study of HPV16 L2E7E6 fusion protein vaccination site post-treatment for HPV16+ cervical cancerStéphanie Gaillard, Jade Alvarez, Tianbei Zhang, et al.
Pageof 12